Rat anti-Souris IgG2a (Heavy Chain) Anticorps
(3 références)Aperçu rapide pour Rat anti-Souris IgG2a (Heavy Chain) Anticorps (ABIN2474718)
Antigène
Clonalité
Application
Clone
Isotype
-
-
Épitope
- Heavy Chain
-
Reactivité
- Souris
-
Hôte
- Rat
-
Attributs du produit
- Purified IgG
-
Purification
- Purified
-
Immunogène
- Purified IgG2a from BALB/c mice
-
-
Goat anti-Mouse IgG2a (Heavy Chain) antibody (HRP)
ELISA, WB, IHC Polyclonal IgG HRP
Rat anti-Mouse IgG2a antibodyELISA, FACS Monoclonal SB84a IgG1 unconjugated
Rat anti-Mouse IgG2a antibody (PE)ELISA, FACS Monoclonal SB84a IgG1 PE
Rat anti-Mouse IgG2a antibody (HRP)ELISA, IHC Monoclonal SB84a IgG1 HRP
Goat anti-Mouse IgG2a (Heavy Chain) antibody (TRITC)ELISA, FACS, IHC Polyclonal IgG TRITC
Goat anti-Mouse IgG2a antibody (PE) - PreadsorbedELISA, FACS Polyclonal IgG PE
Goat anti-Mouse IgG2a antibody (APC) - PreadsorbedELISA, FACS Polyclonal IgG APC
Goat anti-Mouse IgG2a antibody (HRP) - PreadsorbedELISA, FLISA Polyclonal IgG HRP
Goat anti-Mouse IgG2a antibody (Alkaline Phosphatase (AP)) - PreadsorbedELISA, FLISA Polyclonal IgG Alkaline Phosphatase (AP)
Goat anti-Mouse IgG2a (Heavy Chain) antibody (Alkaline Phosphatase (AP))ELISA, WB, IHC Polyclonal IgG Alkaline Phosphatase (AP)
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
-
-
: "Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies." dans: PLoS ONE, Vol. 5, Issue 4, pp. e10105, (2010) (PubMed).
: "Increased B cell proliferation and reduced Ig production in DREAM transgenic mice." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 185, Issue 12, pp. 7527-36, (2010) (PubMed).
: "Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein." dans: Vaccine, Vol. 24, Issue 19, pp. 4102-10, (2006) (PubMed).
-
: "Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies." dans: PLoS ONE, Vol. 5, Issue 4, pp. e10105, (2010) (PubMed).
-
-
